Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009139707 - PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT

Publication Number WO/2009/139707
Publication Date 19.11.2009
International Application No. PCT/SE2009/050524
International Filing Date 12.05.2009
IPC
A61K 31/439 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
439the ring forming part of a bridged ring system, e.g. quinuclidine
A61P 11/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
CPC
A61K 31/439
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
435having six-membered rings with one nitrogen as the only ring hetero atom
439the ring forming part of a bridged ring system, e.g. quinuclidine
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 11/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
11Drugs for disorders of the respiratory system
Applicants
  • ASTRAZENECA AB [SE]/[SE] (AllExceptUS)
  • PULMAGEN THERAPEUTICS (SYNERGY) LIMITED [GB]/[GB] (AllExceptUS)
  • BULL, Richard [GB]/[GB] (UsOnly)
  • FORD, Rhonan [GB]/[GB] (UsOnly)
  • MATHER, Andrew [GB]/[GB] (UsOnly)
  • METE, Antonio [IT]/[GB] (UsOnly)
Inventors
  • BULL, Richard
  • FORD, Rhonan
  • MATHER, Andrew
  • METE, Antonio
Agents
  • ASTRAZENECA AB
Priority Data
0808709.013.05.2008GB
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) PHARMACEUTICAL PRODUCT COMPRISING A MUSCARINIC RECEPTOR ANTAGONIST AND A SECOND ACTIVE INGREDIENT
(FR) PRODUIT PHARMACEUTIQUE COMPRENANT UN ANTAGONISTE DU RÉCEPTEUR MUSCARINIQUE ET UN DEUXIÈME PRINCIPE ACTIF
Abstract
(EN) The invention provides a pharmaceutical product, kit or composition comprising a first active ingredient which is a selected muscarinic receptor antagonist, and a second active ingredient which is selected from a phosphodiesterase inhibitor, a modulator of chemokine receptor function, an inhibitor of kinase function, a protease inhibitor, a steroidal glucocorticoid receptor agonist, a non-steroidal glucocorticoid receptor agonist and a purinoceptor antagonist, of use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma.
(FR) L'invention concerne un produit pharmaceutique, un kit ou une composition comprenant un premier principe actif qui est un antagoniste du récepteur muscarinique sélectionné, et un deuxième principe actif qui est sélectionné parmi un inhibiteur de phosphodiestérase, un modulateur de la fonction du récepteur des chimiokines, un inhibiteur de la fonction kinase, un inhibiteur de protéase, un antagoniste stéroïdien du récepteur des glucocorticoïdes, un agoniste non-stéroïdien du récepteur des glucocorticoïdes et un antagoniste de purinocepteur, à utiliser dans le traitement de maladies respiratoires de type maladie pulmonaire obstructive chronique ou asthme.
Latest bibliographic data on file with the International Bureau